Patent ID: 8535693
Filing Date: 2013-09-17
Classification: A61K,A61P

Abstract:
1. A topical formulation useful for the treatment of inflammation, skin disorders and oral disorders comprising: a composition comprising at least one emulsifier or nonionic surfactant as a solvent; and nanosized particles of at least one component selected from the group consisting of curcumin; bis-O-demethyl curcumin (BDMC); and a mixture of curcumin, bis(demethoxy)curcumin, and demethoxycurcumin; and at least one pharmaceutically acceptable excipient or inactive ingredient; wherein said nanosized particles have a mean particle size of between 1 nm and 50 nm, wherein at least 68% of said nanosized particles have a particle size between 1 nm and 50 nm.